European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

Pier Luigi Zinzani; Lionel Karlin; John Radford; Dolores Caballero; Paul Fields; Martine E D Chamuleau; Francesco d'Amore; Corinne Haioun; Catherine Thieblemont; Eva González-Barca; Carlos Grande García; Peter W Johnson; Gustaaf W van Imhoff; Thomas Ng; Karen Dwyer; Franck Morschhauser

doi:10.3324/haematol.2016.146977

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

Pier Luigi Zinzani, Lionel Karlin, John Radford, Dolores Caballero, Paul Fields, Martine E D Chamuleau, Francesco d'Amore, Corinne Haioun, Catherine Thieblemont, Eva González-Barca, Carlos Grande García, Peter W Johnson, Gustaaf W van Imhoff, Thomas Ng, Karen Dwyer, Franck Morschhauser

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e407-e410
Journal	Haematologica
Volume	101
Issue number	10
DOIs	https://doi.org/10.3324/haematol.2016.146977
Publication status	Published - Oct 2016

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3324/haematol.2016.146977

Cite this

Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D., d'Amore, F., Haioun, C., Thieblemont, C., González-Barca, E., García, C. G., Johnson, P. W., van Imhoff, G. W., Ng, T., Dwyer, K., & Morschhauser, F. (2016). European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. Haematologica, 101(10), e407-e410. https://doi.org/10.3324/haematol.2016.146977

@article{b0763f946dfe4d4b957486e1b80ea3b3,

title = "European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma",

author = "Zinzani, {Pier Luigi} and Lionel Karlin and John Radford and Dolores Caballero and Paul Fields and Chamuleau, {Martine E D} and Francesco d'Amore and Corinne Haioun and Catherine Thieblemont and Eva Gonz{\'a}lez-Barca and Garc{\'i}a, {Carlos Grande} and Johnson, {Peter W} and {van Imhoff}, {Gustaaf W} and Thomas Ng and Karen Dwyer and Franck Morschhauser",

year = "2016",

month = oct,

doi = "10.3324/haematol.2016.146977",

language = "English",

volume = "101",

pages = "e407--e410",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "10",

}

Zinzani, PL, Karlin, L, Radford, J, Caballero, D, Fields, P, Chamuleau, MED, d'Amore, F, Haioun, C, Thieblemont, C, González-Barca, E, García, CG, Johnson, PW, van Imhoff, GW, Ng, T, Dwyer, K & Morschhauser, F 2016, 'European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma', Haematologica, vol. 101, no. 10, pp. e407-e410. https://doi.org/10.3324/haematol.2016.146977

TY - JOUR

T1 - European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

AU - Zinzani, Pier Luigi

AU - Karlin, Lionel

AU - Radford, John

AU - Caballero, Dolores

AU - Fields, Paul

AU - Chamuleau, Martine E D

AU - d'Amore, Francesco

AU - Haioun, Corinne

AU - Thieblemont, Catherine

AU - González-Barca, Eva

AU - García, Carlos Grande

AU - Johnson, Peter W

AU - van Imhoff, Gustaaf W

AU - Ng, Thomas

AU - Dwyer, Karen

AU - Morschhauser, Franck

PY - 2016/10

Y1 - 2016/10

U2 - 10.3324/haematol.2016.146977

DO - 10.3324/haematol.2016.146977

M3 - Article

C2 - 27418646

SN - 0390-6078

VL - 101

SP - e407-e410

JO - Haematologica

JF - Haematologica

IS - 10

ER -